Microcap Ledger Eledon Pharmaceuticals, Inc. $ELDN
Facts as of . Built from SEC filings and our own data. Small caps move fast; check the latest filings.
This page is still filling in. We publish more sections as filings are processed.
Snapshot
- Exchange
- Nasdaq Capital Market
- Sector
- Pharmaceutical Preparations
- Headquarters
- Irvine, CA
- Fiscal year end
- December 31
- Shares outstanding
- 81,261,152 [10-Q 2026-08-13]
Financial health
| Period | Revenue | Net income | Operating cash flow | Cash | Filing |
|---|---|---|---|---|---|
| 6 months to Jun 2026 | — | −$70.66M | −$45.29M | $6.80M | [10-Q 2026-08-13] |
| FY ended Dec 2025 | — | −$45.62M | −$62.34M | $22.81M | [DEF 14A 2026-04-30] |
| FY ended Dec 2024 | — | −$36.18M | −$47.27M | $20.55M | [DEF 14A 2026-04-30] |
- Quarterly cash burn
- −$22.64M
- Cash runway Estimate
- ~0.9 months
Capital structure and dilution
| Date | Shares outstanding | Filing |
|---|---|---|
| 2025-03-17 | 59,881,775 | [10-K 2025-03-20] |
| 2025-05-08 | 59,881,775 | [10-Q 2025-05-14] |
| 2025-08-12 | 59,881,775 | [10-Q 2025-08-14] |
| 2025-08-13 | 59,881,775 | [10-K/A 2025-08-14] |
| 2025-11-07 | 59,932,212 | [10-Q 2025-11-14] |
| 2026-03-13 | 75,851,722 | [10-K 2026-03-19] |
| 2026-05-07 | 77,187,823 | [10-Q 2026-05-13] |
| 2026-08-10 | 81,261,152 | [10-Q 2026-08-13] |
- Shelf registration
- S-3 filed 2026-05-01; declared effective 2026-05-11 [S-3 2026-05-01]
Listing status
Current status: No Form 8-K Item 3.01 (listing notice) filings in the last 24 months, as of 2026-10-11.
Who owns it
| Date | Insider | Type | Shares | Price | Filing |
|---|---|---|---|---|---|
| 2026-07-31 | Gros David-Alexandre C | grant | 354,454 | — | [4 2026-08-04] |
| 2026-07-31 | Gros David-Alexandre C | other | 194,791 | $3.38 | [4 2026-08-04] |
| 2026-07-31 | Perrin Steven | grant | 152,353 | — | [4 2026-08-04] |
| 2026-07-31 | Perrin Steven | other | 72,138 | $3.38 | [4 2026-08-04] |
| 2026-01-10 | Mcbride John S. | exercise | 3,430 | — | [4 2026-01-16] |
| 2026-01-10 | Hillson Jan | exercise | 3,430 | — | [4 2026-01-16] |
| 2026-01-10 | Kirk Allan | exercise | 3,430 | — | [4 2026-01-16] |
| 2026-01-10 | Katkin Keith | exercise | 8,575 | — | [4 2026-01-16] |
| 2026-01-10 | Lee June | exercise | 3,430 | — | [4 2026-01-16] |
| 2026-01-10 | Robinson James A. Jr. | exercise | 3,430 | — | [4 2026-01-16] |
Catalysts and calendar
| Date | Type | Title |
|---|---|---|
| 2026-08-13 | 10-Q | Quarterly report |
| 2026-08-13 | 8-K | Results of operations |
| 2026-07-31 | 13G | Beneficial ownership report (5%+ holder) |
| 2026-06-22 | 8-K | Charter, bylaws or fiscal year change; Shareholder vote results |
| 2026-05-15 | 13G/A | Beneficial ownership report (5%+ holder) |
| 2026-05-13 | 10-Q | Quarterly report |
| 2026-05-13 | 8-K | Results of operations |
| 2026-05-01 | S-3 | Registration statement |
| 2026-04-30 | DEF 14A | Proxy statement |
| 2026-04-27 | 13G | Beneficial ownership report (5%+ holder) |
| 2026-04-21 | PRE 14A | Proxy statement |
| 2026-03-26 | 13G/A | Beneficial ownership report (5%+ holder) |
Alerts for $ELDN
Email me when Eledon Pharmaceuticals, Inc. files an offering, gets a deficiency notice, or moves sharply.
Facts as of . Small caps move fast; check the latest filings.